Stada Arzneimittel Ag
SpainAll drugs from this manufacturer
-
It is used to treat Parkinson's disease, helping to reduce off-time in patients who have already been treated with levodopa or similar medications.
Dosage form: solution for injection in pre-filled pen
Active substance Dosage apomorphine hydrochloride 1000 mg -
It is used to treat Parkinson's disease. It helps reduce the time people spend in an immobile or 'off' state in patients who have previously been treated with levodopa or other dopaminergic agonists.
Dosage form: solution for infusion
Active substance Dosage apomorphine hydrochloride 0,5 % P/V -
It is used to treat Parkinson's disease in adults, helping to reduce the 'off' time (immobility) patients experience when they are already being treated with levodopa or other similar medications.
Dosage form: solution for infusion in cartridge
Active substance Dosage apomorphine hydrochloride 5 mg/ml -
It is used to treat adults with active psoriatic arthritis, moderate to severe chronic plaque psoriasis, and Behçet's disease (to treat mouth ulcers). It is also used in children and adolescents aged 6 years or older weighing at least 20 kg for moderate to severe plaque psoriasis.
Dosage form: tablets, film-coated
Active substance Dosage apremilast 10 mg apremilast 20 mg apremilast 30 mg -
It is used to treat adults with active psoriatic arthritis, moderate to severe chronic plaque psoriasis, and Behçet's disease (specifically for oral ulcers). It is also used in children and adolescents aged 6 years or older with moderate to severe plaque psoriasis, provided their doctor deems it appropriate.
Dosage form: tablets, film-coated
Active substance Dosage apremilast 30 mg -
It is used to treat postmenopausal osteoporosis in women and osteoporosis in men at risk of fracture. It is also used to treat bone loss caused by testosterone reduction in patients with prostate cancer or bone loss due to long-term glucocorticoid treatment.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage denosumab 60 mg -
It is used to treat primary IgA nephropathy in adults aged 18 years and older, helping to reduce inflammation in the intestine.
Dosage form: capsules, hard modified-release
Active substance Dosage budesonide 4 mg -
It is used to treat osteoporosis in adults, helping to increase bone strength and reduce the risk of fractures.
Dosage form: solution for injection
Active substance Dosage teriparatide 0.25 mg -
It is used to treat various types of cancer in adults, including advanced colon or rectal cancer, metastatic breast cancer, advanced non-small cell lung cancer, advanced renal cancer, primary epithelial ovarian, fallopian tube, or peritoneal cancer, and persistent, recurrent, or metastatic cervical cancer.
Dosage form: solution for infusion, concentrate
Active substance Dosage bevacizumab 25 mg -
It is used to treat moderate to severe Crohn's disease in adults and in children weighing at least 40 kg.
Dosage form: solution for infusion, concentrate
Active substance Dosage ustekinumab 130 mg -
It is used to treat inflammatory diseases such as plaque psoriasis (in adults and children aged 6 years and older), psoriatic arthritis (in adults), and Crohn's disease (in adults and children weighing at least 40 kg).
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage ustekinumab 45 mg -
What is Uzpruvo used for?": "It is used to treat plaque psoriasis (in adults and children aged 6 years and older), psoriatic arthritis (in adults), and Crohn's disease (in adults and children weighing at least 40 kg).", "How should I take Uzpruvo?": "It is administered via a subcutaneous injection. Your doctor will decide the dose and the duration of treatment. For psoriasis or psoriatic arthritis, the initial dose is usually 45 mg (or 90 mg if you weigh more than 100 kg), with subsequent doses every 12 weeks. In Crohn's disease, the first dose may be administered intravenously and subsequent doses via subcutaneous injection.", "When should I not use this medicine?": "You should not use it if you are allergic to ustekinumab or any of its components, or if you have an active infection that your doctor considers significant.", "What side effects can Uzpruvo cause?": "It may cause common side effects such as diarrhea, nausea, vomiting, fatigue, dizziness, headache, or itching. Serious side effects may also occur, such as allergic reactions (difficulty breathing or swelling), infections (colds, chest infections, or skin infections), and, in rare cases, heart problems or heart attacks.", "What should I tell my doctor before starting treatment?": "You must inform your doctor if you have had allergic reactions, if you have had cancer, if you have received biological treatments for psoriasis, if you have recent infections, if you are taking other medications, or if you are pregnant or breastfeeding.", "How should I store the medicine?": "It must be stored in a refrigerator between 2 °C and 8 °C, do not freeze. It can be stored at room temperature (up to 30 °C) for a maximum of 30 days in its original box to protect it from light."
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage ustekinumab 90 mg -
It is used in adults to treat various eye diseases that cause vision impairment, such as age-related macular degeneration (AMD), proliferative diabetic retinopathy, macular edema, and other conditions caused by the growth of abnormal blood vessels or swelling in the retina.
Dosage form: solution for injection
Active substance Dosage ranibizumab 2,3 mg